Ally Bridge Group (Ny) LLC Orchard Therapeutics PLC Transaction History

Ally Bridge Group (Ny) LLC

  • $141 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$4.39 - $7.23 $2.4 Million - $3.96 Million
-547,427 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$3.86 - $5.07 $2.11 Million - $2.78 Million
547,427 New
547,427 $2.37 Million

Others Institutions Holding ORTX

# of Institutions
4
Shares Held
545K
Call Options Held
0
Put Options Held
0
View Full List

About Orchard Therapeutics plc

ORTX Quotes by TradingView
  • Ticker ORTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,458,000
  • Description
  • Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...
More about ORTX
Track This Portfolio

Track Ally Bridge Group (Ny) LLC Portfolio

Follow Ally Bridge Group (Ny) LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ally Bridge Group (Ny) LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ally Bridge Group (Ny) LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email